Calier
Calier is a Barcelona-based veterinary pharmaceuticals and biologicals manufacturer, founded 1968, producing 250+ vaccines, antiparasitics, anti-inflammatories, and nutritional supplements for companion animals, poultry, swine, ruminants, and beekeeping across 80+ countries through 12 subsidiaries.
- Company typePrivate
- Founded1968
- HeadquartersBarcelona, Spain
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Calier does
Calier (legal entity Laboratorios Calier S.A.) is a Barcelona-headquartered veterinary pharmaceuticals and biologicals manufacturer founded in 1968 and operating as a subsidiary of the Spanish diversified group Grupo Indukern. The company develops, manufactures, and markets more than 250 products spanning five species verticals: companion animals (dogs, cats, horses, ornamental birds), poultry, swine, ruminants, and beekeeping. Its product portfolio includes biological vaccines, antibiotics, anti-inflammatory drugs, antiparasitics, disinfectants, nutritional supplements, sedatives, and custom autovaccines. The flagship biological franchise centers on Salmonella control in poultry, anchored by Primun Salmonella E, a freeze-dried live attenuated Salmonella Enteritidis vaccine carrying unique antibiotic-resistance markers that enable DIVA differentiation from field strains, and the first live vaccine authorized for use during the laying period by European Medicines Agencies in May 2021. A complementary inactivated bivalent vaccine (Salmonelbac Hidrosa) supports a mixed live-plus-inactivated vaccination strategy.
The company operates four owned production plants in Spain (Les Franqueses del Vallès headquarters plus a biological plant in León), Colombia (Cali), Morocco (Salé), and Uruguay (Montevideo), and distributes through 12 wholly-owned subsidiaries plus third-party distributors to veterinary professionals, farms, and animal production facilities in more than 80 countries across Europe, Latin America, North America, and Africa. Go-to-market is enterprise field sales with species-specialized Technical Services teams advising on-farm solutions, supplemented by the CECADI diagnostic center (PCR-based water and tissue analysis) and the WEVAP digital platform launched in 2022 for auditing poultry vaccination programs via biosafety scoring, preparation checks, application monitoring, and post-vaccination evaluation. The company monetizes primarily through one-time product sales of vaccines and pharmaceuticals, with added-value services layered around technical advice, custom autovaccines, and digital diagnostics.
Revenue is not consolidated publicly; the disclosed Venezuela subsidiary reported 67M EUR in 2022 with 340+ employees, while global headcount figures are inconsistent across sources (firmographics estimate 101-250 globally versus Venezuela alone exceeding 340), suggesting Calier is a mid-tier multinational animal health player with no external venture capital or public market exposure, owned within the Indukern corporate group.
Calier firmographics
Firmographics- Name
- Calier
- Legal name
- Laboratorios Calier S.A.
- Website
- https://calier.com
- Company type
- Private
- Founded year
- 1968
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Calier is a Barcelona-based veterinary pharmaceuticals and biologicals manufacturer, founded 1968, producing 250+ vaccines, antiparasitics, anti-inflammatories, and nutritional supplements for companion animals, poultry, swine, ruminants, and beekeeping across 80+ countries through 12 subsidiaries.
- Ownership category
- akta.pro rank
Calier industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)
- akta.pro secondary industries
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)
Keywords
Where Calier is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices13 records
Markets served
Calier business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Veterinary Pharmaceutical Products: Sale of pharmacological and biological products including vaccines, antibiotics, anti-inflammatory drugs, antiparasitics, disinfectants, nutritional supplements, and sedatives for companion animals and production animals (poultry, swine, ruminants, bees).
- Biological Products: Manufacturing and sale of biological products including live and inactivated vaccines for avian salmonellosis and other animal diseases. Production plants in Spain, Colombia, Morocco, and Uruguay.
- Technical Services: Added-value services including technical advice, farm auditing tools (WEVAP), and specialized technical support by species to help professionals maximize farm performance.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Calier product offering
Product offeringCore offering
Laboratorios Calier S.A. is a veterinary pharmaceutical laboratory founded in 1968 in Barcelona, Spain, that develops, manufactures, and distributes pharmaceutical and biological products for animal health, including vaccines and medicinal specialties for livestock and companion animals. The company operates four production plants (in Spain, Colombia, Morocco, and Uruguay), supports 12 subsidiaries, and markets more than 250 products in over 80 countries.
Product overview
Calier (Laboratorios Calier S.A.) is a veterinary pharmaceuticals company with over 55 years of experience offering a portfolio of more than 250 products across five animal segments: companion animals, poultry, swine, ruminants, and beekeeping. The portfolio includes pharmacological and biological products such as vaccines (Primun Salmonella E, Primun Salmonella T, Salmonelbac Hidrosa, Fixr PRRS Inac), antiparasitics (Dynacan, Merlin), anti-inflammatories (Adocam), nutritional supplements (ComPet line), and autovaccines. Services include CECADI diagnostic center and WEVAP digital vaccination auditing tool. Products are marketed in over 80 countries through 12 subsidiaries with manufacturing plants in Spain, Colombia, Morocco, and Uruguay.
Differentiator
Problem solved
Functional benefit
Brands
- Primun Salmonella E: Live attenuated Salmonella Enteritidis vaccine for poultry, first authorized for use during laying period
- Primun Salmonella T
- Dynacan
- Merlin
- Adocam
- SalmonelBac Hidrosa
- ComPet
- CECADI
- WEVAP
Products and services
- Primun Salmonella E Salmonella vaccine for poultry, part of Calier's range of biological products aimed at preventing salmonellosis in livestock production.
- WEVAP Veterinary pharmaceutical/biological product contributing to Calier's portfolio of more than 250 animal health products sold worldwide.
Quantifiable outcome
- Primun Salmonella E demonstrated protection up to 95 weeks of life in layers
- +4 more outcomes
Companies that use Calier
Customer profileSegments6 records
Ideal customer profiles2 records
Calier technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Calier partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- Fundación Amigos de las Abejas (Friends of Bees Foundation)minorCharitable partnership as part of the 'Zumbados por las Abejas' project. Calier donates 3€ per photograph received in their Beekeeping Photo Contest to support awareness programs about pollinating insects and ecosystem conservation.
- Sierras AndaluzasminorSector partnership for beekeeping awareness and promotion of technical knowledge and local honey consumption in Andalusia, Spain.
- La TarragoninaminorSector partnership for beekeeping sector promotion and technical knowledge sharing in the Tarragona region.
- FunbrainminorEducational content collaboration to create digital educational materials about bees and beekeeping for schools across Spain as part of the 'Zumbados por las Abejas' project.
- Ambientech FoundationminorCollaboration on educational materials and workshops in schools about the importance of beekeeping and ecosystem balance.
- Microsoft 365minorCloud-based productivity and collaboration tools provider located outside the EU but compliant with GDPR regulations.
- SalesforceminorCustomer relationship management platform provider located outside the EU but compliant with GDPR regulations.
- External Sample Collection CompaniesminorPartnership with external companies specializing in sample collection and water quality testing in Spain to provide comprehensive WEVAP vaccination audit services.
- INTA Argentina (Instituto Nacional de Tecnología Agropecuaria)coreResearch partnership with INTA Argentina led by Dr. Pablo Chacana for conducting vaccine efficacy challenge trials using Salmonella Enteritidis strains, in coordination with SENASA (National Agricultural Health and Quality Department).
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
Calier competitors and assessment
Company assessmentDirect peers
- Vetoquinol: Independent French veterinary pharmaceutical company with portfolio of pharmaceuticals, parasiticides, and nutrition products for companion and production animals. Similar size, private-listed mid-cap profile, and therapeutic overlap.
- Dechra Pharmaceuticals: UK-based specialty veterinary pharmaceuticals company acquired by EQT, with strong portfolio in companion animal endocrinology, dermatology, and anti-infectives. Comparable on mid-cap specialty pharma positioning though more companion-animal weighted.
- Virbac: Independent French animal health company offering vaccines, pharmaceuticals, and diagnostics across companion and production animals. Similar mid-cap profile, broad species portfolio, and direct overlap in antiparasitics and biologicals.
- Hipra: Spanish-headquartered veterinary biologics and pharmaceuticals company specializing in animal vaccines (especially poultry and swine) with global presence. Most direct comparable on geography, species focus, and biological manufacturing scale to Calier.
- Phibro Animal Health: US-listed animal health and nutrition company focused on livestock (poultry, swine, cattle) vaccines, medicated feed additives, and minerals. Comparable on production-animal emphasis and biologicals manufacturing, particularly in poultry.
- Ceva Santé Animale: French-based global animal health player focused on vaccines, pharmaceuticals, and companion animal products with significant poultry vaccine franchise. Comparable on species mix, biologicals emphasis, and private ownership structure.
Broad incumbents
- Elanco Animal Health: Large global animal health company spanning companion animal, livestock, and poultry therapeutics and vaccines. Broad incumbent competitor across all of Calier's species segments.
- Boehringer Ingelheim Animal Health: Global animal health division of Boehringer Ingelheim, with major positions in poultry and swine vaccines including PRRS. Direct competitor in Calier's swine PRRS vaccine franchise (Fixr PRRS Inac).
- Zoetis: World's largest pure-play animal health company with the broadest portfolio across species, therapeutics, vaccines, diagnostics, and digital. Represents the dominant incumbent Calier competes against across multiple species segments.
Emerging players
- Innovacyn: US-based animal health company specializing in wound care, dermatology, and nutritional supplements for companion and production animals. Niche overlap in companion animal supplements (ComPet line category).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Calier social profiles
Digital presenceCalier financial estimates
Financial estimateRevenue estimate
Valuation estimate
Calier leadership team
Management profileNumber of profiles
Profiles1 record
Calier subsidiaries and ownership
Company hierarchySubsidiaries12 records
Calier funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Calier M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Calier
What does Calier do?
Laboratorios Calier S.A. is a veterinary pharmaceutical laboratory founded in 1968 in Barcelona, Spain, that develops, manufactures, and distributes pharmaceutical and biological products for animal health, including vaccines and medicinal specialties for livestock and companion animals. The company operates four production plants (in Spain, Colombia, Morocco, and Uruguay), supports 12 subsidiaries, and markets more than 250 products in over 80 countries.
Is Calier a public or private company?
Calier is a private company. It is classified as corporate owned and is currently operating.
When was Calier founded?
Calier was founded in 1968. It employs 101 to 250 people.
Where is Calier based?
Calier is headquartered in Barcelona, Spain, in the Europe region.
How does Calier make money?
Three revenue lines are on record. Veterinary Pharmaceutical Products are the primary driver. The others are biological Products and technical Services.
Who are Calier's main competitors?
Direct peers on record are Vetoquinol, Dechra Pharmaceuticals, Virbac, Hipra, Phibro Animal Health and Ceva Santé Animale. Broad incumbents are Elanco Animal Health, Boehringer Ingelheim Animal Health and Zoetis. Innovacyn is listed as an emerging player.
Does Calier have an API?
No public API is recorded for Calier.
What industry is Calier in?
Calier's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAKAI, Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325412 and its SIC code is 2834.